Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
AIDS (London, England)|July 9, 1999
Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 InvestigatorsD R Kuritzkes, I Marschner, V A Johnson, et al.
JAMA|June 27, 1998
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA PanelM S Hirsch, B Conway, R T D'Aquila, et al.
JAMA|May 18, 2000
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA PanelM S Hirsch, F Brun-Vézinet, R T D'Aquila, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
The Journal of Infectious Diseases|January 7, 1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapyI C Marschner, A C Collier, R W Coombs, et al.
Cell|January 5, 2024
Microbial transmission in the social microbiome and host health and diseaseAmar Sarkar, Cameron J A McInroy, Siobhán Harty, et al.
The Journal of Infectious Diseases|October 1, 1996
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 TeamS L Welles, J B Jackson, B Yen-Lieberman, et al.
Pageof 8